EN
HI
Summary
As of 30 Sep, 2026, Parmax Pharma stock price is ₹137.75. During the trading session, the stock has moved between an intraday low of ₹136.95 and an intraday high of ₹137.75. Over the last 52 weeks, Parmax Pharma has traded between ₹0.00 and ₹137.75.
The stock has recorded a trading volume of 16,216 shares,. Its Average Traded Price (ATP) is ₹137.72, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 300 @ ₹137.75.
Parmax Pharma has an upper circuit limit of ₹139.10 and a lower circuit limit of ₹136.40. The total value traded stands at ₹22.33 L, and the delivery percentage for the day is -1%.
The stock is currently traded with a market lot size of 1. Parmax Pharma also offers a dividend yield of 0%.
Parmax Pharma Share Price Chart
Parmax Pharma Share Key Metrics
Volume
16216.00
Market Cap
94.76 CR
LTQ@LTP
300@137.75
ATP
137.72
Var Margin
0 %
Circuit Range
136.4-139.1
Delivery %
- %
Value
22.33 L
ASM/GSM
No
Market Lot
1
Parmax Pharma Resistance and Support
Pivot 137.48
Resistance
First Resistance
138.01
Second Resistance
138.28
Third Resistance
138.81
Support
First Support
137.21
Second Support
136.68
Third Support
136.41
Parmax Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Sep 28 2026 | 137.19 | 137.75 | 1.00% | 137.75 | 136.94 |
| Mon Sep 21 2026 | 136.39 | 136.39 | 0.99% | 136.39 | 136.39 |
| Tue Sep 15 2026 | 135.05 | 135.05 | 0.97% | 135.05 | 135 |
Parmax Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-06-08 | Fund raising |
| 2026-06-02 | Audited Results |
| 2026-05-30 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Parmax Pharma News
Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Parmax Pharma's promoter and promoter group increased their total diluted shareholding to 68.34% from 58.01% after acquiring 39.97 lakh equity shares and warrants through a preferential allotment. The acquisition was completed on August 29, 2026.
Sep 02 2026 10:47:01
Parmax Pharma Management
| Name | Position |
|---|---|
| Umang A Gosalia | Managing Director |
| Nikhil Uchat | Non Executive Independent Director |
Parmax Pharma Similar Stocks
Beryl Drugs Ltd.
25.65
1.10 (4.48%)
Sharma East India Hospitals & Medical Research Ltd
88.00
2.70 (3.17%)
Norris Medicines Ltd.
17.15
-0.90 (4.99%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Colinz Laboratories Ltd.
76.69
1.73 (2.31%)
Broach Lifecare Hospital Ltd.
15.00
0.00 (0.00%)
Unjha Formulations Ltd.
32.50
0.50 (1.56%)
Ortin Global Ltd.
14.88
0.00 (0.00%)
Starsource Multitrade Ltd.
81.25
3.86 (4.99%)
Parmax Pharma FAQs
The Buying Price of Parmax Pharma share is 137.75 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Parmax Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Parmax Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Parmax Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Parmax Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Parmax Pharma’s valuation compare Sector P/E, P/B which are 43.56 & 3.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Parmax Pharma is 94.76 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Parmax Pharma share price is 137.75 & 0.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Parmax Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in PARMAX
